CERO is a wild card for traders craving action. This high-volatility ticker can rocket sky-high or dive deep—perfect for those ready to capitalize on sharp swings. Timing is everything, so ride the momentum and lock in gains!
Note
A significant pipeline drug gaining approval would boost investor confidence.
Securing funding or partnerships with larger pharmaceutical companies.
Increased Revenue: Reporting earnings or securing grants that reduce cash burn
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.